The Roundtable on Genomics and Precision Health will host a public workshop on June 27, 2018 to explore disparities in access to genetic/genomic services that exist across different segments of the population (e.g., in medically underserved areas and populations, across different racial/ethnic groups, and socioeconomic levels). The workshop may discuss model programs of care for diverse patient populations, with a focus on examining current challenges, approaches, and best practices for alleviating disparities in access, which may include the geographic distribution of providers and services and the potential role of telemedicine. Workshop discussions may also focus on insurance coverage for genetic/genomic services, along with the financial costs for patients of genetic testing and downstream care.

On July 11, 2018, the Roundtable on Health Literacy will host a workshop focused on the intersection of behavioral health, mental health, and health literacy.

The National Cancer Policy Forum will hold a public workshop on July 16-17, 2018 to examine the opportunities to improve the clinical development of immune checkpoint inhibitor therapies for cancer, including in the context of site-agnostic indications.

An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine (NASEM) will plan and conduct a three-part workshop series to be held over the course of a two-year period. As part of FDA's continued focus on building a national governance system for evidence generation, the proposed focus of these workshops will be on the generation and utilization of real-world evidence to evaluate efficacy, effectiveness, tolerability, and safety for both review of new indications and postapproval studies. These workshops would include presentations and perspectives from thought and knowledge leaders representing a range of disciplines, including but not limited to federal regulatory and funding agencies, clinical and academic medicine and research, medical professional organizations, the regulated biopharmaceutical industry, patients and patient-focused and disease-advocacy organizations, payers, consumer organizations, health systems, and other interested stakeholders that represent the myriad views of those involved in drug, biologic, and device discovery, development, translation, and regulation. The workshop audiences are expected to be similarly diverse, and they will have opportunities to engage in discussion during the workshops.

The Roundtable on Quality Care for People with Serious Illness will host a public workshop on the integration of health and social services and its impact on people with serious illness.

The Food Forum will host a public workshop on August 1-2, 2018 that will review the current and emerging knowledge on the concept of sustainable diets within the field of food and nutrition.

On August 6, 2018, the committee on Applying Neurobiological and Socio-behavioral Sciences from Prenatal through Early Childhood Development: A Health Equity Approach will host a workshop at the Keck Center of the National Academies.

On October 3, 2018, the Roundtable on Population Health Improvement and the Interdisciplinary Association for Population Health Science (IAPHS) will hold a half-day joint symposium Population Health Science in the United States: Trends, Evidence, and Effective Policy.

Committee Only
The second meeting of the Committee on a National Strategy for Cancer Control in the United States will be on October 8-10, 2018 at the Arnold and Mabel Beckman Center of the National Academies located at 100 Academy Drive, Irvine, CA 92617. All days will be closed sessions.

The workshop will be held on October 29 – 30, 2018 to examine the clinical use of high-dimensional omics data and computational methods in precision oncology research and clinical care.